Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Exact Sciences Corporation (EXAS)

114.95   -1.24 (-1.07%) 07-16 16:00
Open: 116.62 Pre. Close: 116.19
High: 118.595 Low: 114.75
Volume: 921,298 Market Cap: 14845M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 117.505 - 118.215 118.215 - 118.895
Low: 112.349 - 113.176 113.176 - 113.968
Close: 114.912 - 116.14 116.14 - 117.317

Technical analysis

as of: 2019-07-16 3:20:38 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 142.47     One year: 166.41
Support: Support1: 113.59    Support2: 108.41
Resistance: Resistance1: 121.98    Resistance2: 142.47
Pivot: 116.50
Moving Average: MA(5): 116.53     MA(20): 116.20
MA(100): 99.85     MA(250): 82.27
MACD: MACD(12,26): 2.56     Signal(9): 3.32
Stochastic oscillator: %K(14,3): 47.58     %D(3): 51.89
RSI: RSI(14): 54.98
52-week: High: 121.98  Low: 47.78  Change(%): 73.2
Average Vol(K): 3-Month: 156342  10-Days: 103619

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
EXAS has closed above bottom band by 40.3%. Bollinger Bands are 33.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 15 Jul 2019 14:07:13 Z
The EXAS Paradox: Analysts Bullish But Forecast -1.26% Fall

Mon, 08 Jul 2019 23:07:57 Z
Notable Monday Option Activity: EXAS, TIF, PETS

Mon, 08 Jul 2019 16:11:22 Z
Why Exact Sciences Corporation Stock Gained Nearly 14% in June

Fri, 28 Jun 2019 21:07:41 Z
Noteworthy Friday Option Activity: YETI, EXAS, ARLO

Thu, 27 Jun 2019 17:08:28 Z
EXAS August 9th Options Begin Trading

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Diagnostics Research
Shares Out. (M) 129.14
Shares Float (M) 127.31
% Held by Insiders 2.00
% Held by Institutions 90.27
Shares Short (K) 13050
Shares Short P. Month (K)

Stock Financials

EPS -1.770
EPS Est. Current Year -1.170
EPS Est. Next Year -0.710
EPS Est. Next Quarter -0.280
Forward EPS -0.440
Book Value (p.s.) 6.020
PEG Ratio -2.72
Profit Margin -41.58
Operating Margin -36.32
Return on Assets (ttm) -7.9
Return on Equity (ttm) -29.9
Qtrly Rev. Growth 79.5
Gross Profit (p.s.) 2.606
Sales Per Share
EBITDA (p.s.) -1.284
Qtrly Earnings Growth
Operating Cash Flow (M) -105.21
Levered Free Cash Flow (M) -133.35

Stock Valuations

P/E -65.31
P/E Growth Ratio -0.01
P/BV 19.20
P/S 3504362496.00
P/CF -141.89

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.